Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Benzamide, 2-hydroxy-N-[(1S,2S,6S)-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]- REF: IN-DA002W95CAS: 287194-40-5 | 98.47% | A consultar | Jue 21 Nov 24 | |
Dehydroxymethylepoxyquinomicin REF: 4Z-B-118007CAS: 287194-40-5 | - - - | A consultar | Vie 29 Nov 24 | |
DHMEQ REF: 3D-MLA19440CAS: 287194-40-5 | Min. 95% | A consultar | Jue 02 Ene 25 |
Benzamide, 2-hydroxy-N-[(1S,2S,6S)-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-
CAS:287194-40-5
Fórmula:
C13H11NO5
Pureza:
98.47%
Forma y color:
Solid
Peso molecular:
261.2301
Ref: IN-DA002W95
2mg | 548,00 € | ||
5mg | 605,00 € | ||
10mg | A consultar | ||
25mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 21 de Noviembre de 2024
Ref: 4Z-B-118007
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 29 de Noviembre de 2024
DHMEQ
CAS:287194-40-5
(-)-DHMEQ is a potent inhibitor of NF-κB activation, which is an intracellular protein that regulates …
Fórmula:
C13H11NO5
Pureza:
Min. 95%
Forma y color:
Powder
Peso molecular:
261.23 g/mol
Ref: 3D-MLA19440
1mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 2 de Enero de 2025